Natus Neurology Incorporated, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and Health Canada clearance for its new electrodiagnostic system, the UltraPro S100 EMG System. The UltraPro S100 is an EMG/Nerve Conduction device for monitoring and testing electrophysiologic and electrodiagnostic information from the human nervous and muscular system.
“We are excited to bring the new UltraPro S100 EMG System to the U.S. & Canadian markets,” said Austin Noll, Vice President and General Manager of Natus Medical Incorporated. “The UltraPro S100 helps strengthen our market-leading EMG portfolio and ensures clinicians and patients can benefit from the latest advancements in neurological care.”
Built on the 60-year heritage of Nicolet, Dantec, XLTEK and Teca brands, the UltraPro S100 brings reliability, performance, portability and exceptional value to U.S. & Canadian clinicians. It features easy-to-use reports, efficient connectivity to electronic medical records, distinctive function keys, online summaries and a built-in reference value database.
Designed with input from neurologists and electrodiagnostic technicians, UltraPro S100 helps improve workflow in busy clinical settings by effectively organizing data into a variety of automated reporting formats. With this versatile system, clinicians can complete their studies and generate reports with ease, helping to streamline workflow, improving clinician efficiency and lowering costs.
The UltraPro S100 EMG System is now available to order and ship immediately to U.S. & Canadian customers. It will be featured at the Natus Neurology booth at leading U.S. & Canadian trade shows throughout the year.
Natus Medical Incorporated (NASDAQ: BABY) is a leading provider of medical devices, software and services for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories world-wide. For more information about Natus, please visit www.natus.com.
